These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37643152)

  • 1. Engineering a
    Teng Y; Wang J; Jiang T; Zou Y; Yan Y
    ACS Synth Biol; 2023 Sep; 12(9):2764-2772. PubMed ID: 37643152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring and engineering PAM-diverse Streptococci Cas9 for PAM-directed bifunctional and titratable gene control in bacteria.
    Wang J; Teng Y; Gong X; Zhang J; Wu Y; Lou L; Li M; Xie ZR; Yan Y
    Metab Eng; 2023 Jan; 75():68-77. PubMed ID: 36404524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
    Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
    Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Mechanism of D1135E-Induced Discriminated CRISPR-Cas9 PAM Recognition.
    Kang M; Zuo Z; Yin Z; Gu J
    J Chem Inf Model; 2022 Jun; 62(12):3057-3066. PubMed ID: 35666156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural insights into a high fidelity variant of SpCas9.
    Guo M; Ren K; Zhu Y; Tang Z; Wang Y; Zhang B; Huang Z
    Cell Res; 2019 Mar; 29(3):183-192. PubMed ID: 30664728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity.
    Hu JH; Miller SM; Geurts MH; Tang W; Chen L; Sun N; Zeina CM; Gao X; Rees HA; Lin Z; Liu DR
    Nature; 2018 Apr; 556(7699):57-63. PubMed ID: 29512652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Basis for the Altered PAM Specificities of Engineered CRISPR-Cas9.
    Hirano S; Nishimasu H; Ishitani R; Nureki O
    Mol Cell; 2016 Mar; 61(6):886-94. PubMed ID: 26990991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal PAM specificity of a highly similar SpCas9 ortholog.
    Chatterjee P; Jakimo N; Jacobson JM
    Sci Adv; 2018 Oct; 4(10):eaau0766. PubMed ID: 30397647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of the affinities of CRISPR-Cas9 nucleases for cognate protospacer adjacent motif (PAM) sequences.
    Mekler V; Kuznedelov K; Severinov K
    J Biol Chem; 2020 May; 295(19):6509-6517. PubMed ID: 32241913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding the scope of CRISPR/Cas9-mediated genome editing in plants using an xCas9 and Cas9-NG hybrid.
    Niu Q; Wu S; Li Y; Yang X; Liu P; Xu Y; Lang Z
    J Integr Plant Biol; 2020 Apr; 62(4):398-402. PubMed ID: 31702097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the mechanisms of PAMless DNA interrogation by SpRY-Cas9.
    Hibshman GN; Bravo JPK; Hooper MM; Dangerfield TL; Zhang H; Finkelstein IJ; Johnson KA; Taylor DW
    Nat Commun; 2024 Apr; 15(1):3663. PubMed ID: 38688943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering a PAM-flexible SpdCas9 variant as a universal gene repressor.
    Wang J; Teng Y; Zhang R; Wu Y; Lou L; Zou Y; Li M; Xie ZR; Yan Y
    Nat Commun; 2021 Nov; 12(1):6916. PubMed ID: 34824292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding PAM recognition and enhancing base editing activity of Cas9 variants with non-PI domain mutations derived from xCas9.
    Xie L; Hu Y; Li L; Jiang L; Jiao Y; Wang Y; Zhou L; Tao R; Qu J; Chen Q; Yao S
    FEBS J; 2022 Oct; 289(19):5899-5913. PubMed ID: 35411720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease.
    Chen W; Zhang H; Zhang Y; Wang Y; Gan J; Ji Q
    PLoS Biol; 2019 Oct; 17(10):e3000496. PubMed ID: 31603896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome Editing in Zebrafish by ScCas9 Recognizing NNG PAM.
    Liu Y; Liang F; Dong Z; Li S; Ye J; Qin W
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Plasticity of PAM Recognition by Engineered Variants of the RNA-Guided Endonuclease Cas9.
    Anders C; Bargsten K; Jinek M
    Mol Cell; 2016 Mar; 61(6):895-902. PubMed ID: 26990992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered CRISPR-Cas9 nuclease with expanded targeting space.
    Nishimasu H; Shi X; Ishiguro S; Gao L; Hirano S; Okazaki S; Noda T; Abudayyeh OO; Gootenberg JS; Mori H; Oura S; Holmes B; Tanaka M; Seki M; Hirano H; Aburatani H; Ishitani R; Ikawa M; Yachie N; Zhang F; Nureki O
    Science; 2018 Sep; 361(6408):1259-1262. PubMed ID: 30166441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered dual selection for directed evolution of SpCas9 PAM specificity.
    Goldberg GW; Spencer JM; Giganti DO; Camellato BR; Agmon N; Ichikawa DM; Boeke JD; Noyes MB
    Nat Commun; 2021 Jan; 12(1):349. PubMed ID: 33441553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-depth assessment of the PAM compatibility and editing activities of Cas9 variants.
    Zhang W; Yin J; Zhang-Ding Z; Xin C; Liu M; Wang Y; Ai C; Hu J
    Nucleic Acids Res; 2021 Sep; 49(15):8785-8795. PubMed ID: 34133740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing the efficiency of CRISPR-Cas9-VQR precise genome editing in rice.
    Hu X; Meng X; Liu Q; Li J; Wang K
    Plant Biotechnol J; 2018 Jan; 16(1):292-297. PubMed ID: 28605576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.